{"id":1650,"date":"2026-06-17T19:46:23","date_gmt":"2026-06-17T23:46:23","guid":{"rendered":"https:\/\/www.insilens.com\/?p=1650"},"modified":"2026-06-17T19:47:40","modified_gmt":"2026-06-17T23:47:40","slug":"be-bio-terminates-be-101-hemophilia-b-program","status":"publish","type":"post","link":"https:\/\/www.insilens.com\/?p=1650","title":{"rendered":"Be Bio Terminates BE-101 Hemophilia B Program"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"1650\" class=\"elementor elementor-1650\">\n\t\t\t\t<div class=\"elementor-element elementor-element-4e824ad8 e-flex e-con-boxed e-con e-parent\" data-id=\"4e824ad8\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-2edee3b0 elementor-widget elementor-widget-image\" data-id=\"2edee3b0\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"image.default\">\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<img fetchpriority=\"high\" decoding=\"async\" width=\"768\" height=\"512\" src=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-17-2026-07_45_54-PM-768x512.png\" class=\"attachment-medium_large size-medium_large wp-image-1651\" alt=\"\" srcset=\"https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-17-2026-07_45_54-PM-768x512.png 768w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-17-2026-07_45_54-PM-300x200.png 300w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-17-2026-07_45_54-PM-1024x683.png 1024w, https:\/\/www.insilens.com\/wp-content\/uploads\/2026\/06\/ChatGPT-Image-Jun-17-2026-07_45_54-PM.png 1536w\" sizes=\"(max-width: 768px) 100vw, 768px\" \/>\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t<div class=\"elementor-element elementor-element-296540d5 e-flex e-con-boxed e-con e-parent\" data-id=\"296540d5\" data-element_type=\"container\" data-e-type=\"container\">\n\t\t\t\t\t<div class=\"e-con-inner\">\n\t\t\t\t<div class=\"elementor-element elementor-element-3c9f87fc elementor-widget__width-inherit elementor-widget elementor-widget-text-editor\" data-id=\"3c9f87fc\" data-element_type=\"widget\" data-e-type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t\t\t\t\t\t<h4>Summary<\/h4><p>Be Biopharma terminated the Phase 1\/2 BeCoMe-9 study of BE-101, the first engineered B cell medicine tested clinically in hemophilia B.<\/p><h4>What Happened<\/h4><p>The trial stopped after enrolling five patients. The company stated the decision was strategic and not driven by safety concerns.<\/p><h4>Deep Analysis<\/h4><p>This is a platform-level event. Engineered B cell medicines were positioned as a potential alternative to AAV gene therapy through durable, titratable and potentially re-dosable protein production. While not a biological failure, the termination removes the leading opportunity for clinical validation of the modality. It also reflects the increasingly difficult commercial and financing environment surrounding genetic medicines in hemophilia.<\/p><h4>Competitive Displacement<\/h4><p>Established approaches including HEMGENIX, BEQVEZ, fitusiran and concizumab face less near-term competition from engineered B cell therapies.<\/p><h4>Company \/ Product Background<\/h4><p>BE-101 was designed to engineer patient B cells to produce Factor IX without conditioning chemotherapy.<\/p><h4>Signal Extraction<\/h4><p>First B cell medicine trial terminated; no reported safety signal; platform implications beyond hemophilia; highlights capital allocation pressures in genetic medicine.<\/p><h4>Insilens Take<\/h4><p>The most important takeaway is that the field loses its best near-term proof-of-concept opportunity. This is a setback for engineered B cell therapeutics, though not evidence that the underlying science is invalid.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>Summary Be Biopharma terminated the Phase 1\/2 BeCoMe-9 study of BE-101, the first engineered B cell medicine tested clinically in hemophilia B. What Happened The trial stopped after enrolling five patients. The company stated the decision was strategic and not driven by safety concerns. Deep Analysis This is a platform-level event. Engineered B cell medicines [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1651,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1,3],"tags":[],"class_list":["post-1650","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-all-categories","category-therapeutic-indication"],"blocksy_meta":[],"_links":{"self":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1650","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=1650"}],"version-history":[{"count":4,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1650\/revisions"}],"predecessor-version":[{"id":1655,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/posts\/1650\/revisions\/1655"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=\/wp\/v2\/media\/1651"}],"wp:attachment":[{"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=1650"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=1650"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.insilens.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=1650"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}